GB202312279D0 - New compounds and uses - Google Patents

New compounds and uses

Info

Publication number
GB202312279D0
GB202312279D0 GBGB2312279.9A GB202312279A GB202312279D0 GB 202312279 D0 GB202312279 D0 GB 202312279D0 GB 202312279 A GB202312279 A GB 202312279A GB 202312279 D0 GB202312279 D0 GB 202312279D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2312279.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technische Universitaet Muenchen
Universiteit Leiden
Original Assignee
Technische Universitaet Muenchen
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universitaet Muenchen, Universiteit Leiden filed Critical Technische Universitaet Muenchen
Priority to GBGB2312279.9A priority Critical patent/GB202312279D0/en
Publication of GB202312279D0 publication Critical patent/GB202312279D0/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
GBGB2312279.9A 2023-08-10 2023-08-10 New compounds and uses Pending GB202312279D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2312279.9A GB202312279D0 (en) 2023-08-10 2023-08-10 New compounds and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2312279.9A GB202312279D0 (en) 2023-08-10 2023-08-10 New compounds and uses

Publications (1)

Publication Number Publication Date
GB202312279D0 true GB202312279D0 (en) 2023-09-27

Family

ID=88093322

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2312279.9A Pending GB202312279D0 (en) 2023-08-10 2023-08-10 New compounds and uses

Country Status (1)

Country Link
GB (1) GB202312279D0 (en)

Similar Documents

Publication Publication Date Title
EP4247815A4 (en) Compounds and uses thereof
EP4096657A4 (en) Compounds and uses thereof
GB202004094D0 (en) New compounds and uses
IL304222A (en) Substituted pyridotriazine compounds and uses thereof
GB202015035D0 (en) New compounds and methods
GB202015044D0 (en) New compounds and methods
IL311521A (en) Egfrviii-targeted compounds and uses thereof
GB2609814B (en) Terpenophenolic compounds and their use
GB202104122D0 (en) Compounds and their use
GB202312279D0 (en) New compounds and uses
GB202314282D0 (en) New compounds and uses thereof
GB202102243D0 (en) New compounds and uses
IL314757A (en) Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses
GB202318964D0 (en) Novel compounds and uses thereof
GB202307065D0 (en) Novel compounds and uses thereof
GB202202851D0 (en) Novel compounds and uses thereof
GB202202852D0 (en) Novel compounds and uses thereof
GB202208257D0 (en) Novel compounds and their uses
GB202208260D0 (en) Novel compounds and their uses
GB202105483D0 (en) Compounds and uses thereof
GB202303237D0 (en) Compounds and their use
GB202216665D0 (en) Compounds and their use
GB202318929D0 (en) New compounds and methods
GB202213310D0 (en) New compounds and methods
GB202204085D0 (en) New compounds and methods